Literature DB >> 25480740

Bronchiolitis obliterans organizing pneumonia in patients with autoimmune rheumatic diseases.

Carmen Maria Lara Rojas1, Elisabetta Borella, Lavinia Palma, Silvio Ragozzino, Enrique De Ramón, Ricardo Gomez-Huelgas, Leonardo Punzi, Andrea Doria.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is defined by buds of granulation tissue within lung distal airspaces. The diagnosis requires the histopathologic evidence of organizing pneumonia along with a suggestive clinical and radiographic pattern. This disorder is characterized by a good response to corticosteroids and an excellent prognosis. It can occur in association with a broad spectrum of clinical conditions or can be isolated, in this last case named cryptogenic organizing pneumonia. We searched for BOOP in patients with autoimmune rheumatic diseases (ARD) in the literature, and we found 32 well-documented cases. We reported here demographic features, manifestations, treatment and outcome of patients with BOOP associated with ARD. Notably, BOOP can be the presenting feature in some patients with ARD; thus, a close follow-up of patients with BOOP is recommended.

Entities:  

Mesh:

Year:  2015        PMID: 25480740     DOI: 10.1007/s12026-014-8607-z

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  45 in total

1.  [Bronchiolitis obliterans with organized pneumonia: a rare complication of primary Gougerot-Sjögren syndrome].

Authors:  M Lambert; M Hebbar; N Viget; P Y Hatron; E Hachulla; B Devulder
Journal:  Rev Med Interne       Date:  2000-01       Impact factor: 0.728

2.  Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid.

Authors:  Daizo Koinuma; Makoto Miki; Masahito Ebina; Minoru Tahara; Koichi Hagiwara; Takashi Kondo; Yoshio Taguchi; Toshihiro Nukiwa
Journal:  Intern Med       Date:  2002-01       Impact factor: 1.271

3.  Cyclophosphamide therapy is effective for bronchiolitis obliterans occurring as a late manifestation of lupus erythematosus.

Authors:  F Weber; C Prior; E Kowald; M Schmuth; N Sepp
Journal:  Br J Dermatol       Date:  2000-08       Impact factor: 9.302

4.  Bronchiolitis obliterans organizing pneumonia as the first manifestation of polymyositis.

Authors:  F Fata; R Rathore; C Schiff; B C Herzlich
Journal:  South Med J       Date:  1997-02       Impact factor: 0.954

5.  Organizing pneumonia in a patient with rheumatoid arthritis treated with etanercept.

Authors:  Hiroyuki Sakaida; Yuko Komase; Tamiko Takemura
Journal:  Mod Rheumatol       Date:  2010-06-24       Impact factor: 3.023

6.  Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.

Authors:  I Kobayashi; M Yamada; Y Takahashi; N Kawamura; M Okano; Y Sakiyama; K Kobayashi
Journal:  Rheumatology (Oxford)       Date:  2003-02       Impact factor: 7.580

7.  Bronchiolitis obliterans in systemic lupus erythematosus: beneficial effect of intravenous cyclophosphamide.

Authors:  B Godeau; C Cormier; C J Menkes
Journal:  Ann Rheum Dis       Date:  1991-12       Impact factor: 19.103

Review 8.  Pneumomediastinum and subcutaneous emphysema secondary to amyopathic dermatomyositis with cryptogenic organizing pneumonia in invasive breast cancer: a case report and review of literature.

Authors:  Sung Hwan Park; Yoon-Seup Kum; Kyung-Chan Kim; Jung-Yoon Choe; Sung-Hoon Park; Seong-Kyu Kim
Journal:  Rheumatol Int       Date:  2008-12-18       Impact factor: 2.631

9.  [Refractory dermatomyositis associated with chronic organizing pneumonia treated with rituximab: report of one case].

Authors:  Jorge Yáñez V; Marcela Cisternas M; Velia Saldías H; Fernando Saldías P
Journal:  Rev Med Chil       Date:  2009-04-23       Impact factor: 0.553

10.  Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus.

Authors:  R B Gammon; T A Bridges; H al-Nezir; C B Alexander; J I Kennedy
Journal:  Chest       Date:  1992-10       Impact factor: 9.410

View more
  2 in total

Review 1.  Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management.

Authors:  Elena De Zorzi; Paolo Spagnolo; Elisabetta Cocconcelli; Elisabetta Balestro; Luca Iaccarino; Mariele Gatto; Francesco Benvenuti; Nicol Bernardinello; Andrea Doria; Toby M Maher; Elisabetta Zanatta
Journal:  Clin Rev Allergy Immunol       Date:  2022-03-18       Impact factor: 10.817

Review 2.  PD-1 inhibitors increase the incidence and risk of pneumonitis in cancer patients in a dose-independent manner: a meta-analysis.

Authors:  Jiaying Wu; Dongsheng Hong; Xiangnan Zhang; Xiaoyang Lu; Jing Miao
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.